346 related articles for article (PubMed ID: 11350724)
21. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
22. EGF/ErbB receptor family in ovarian cancer.
Maihle NJ; Baron AT; Barrette BA; Boardman CH; Christensen TA; Cora EM; Faupel-Badger JM; Greenwood T; Juneja SC; Lafky JM; Lee H; Reiter JL; Podratz KC
Cancer Treat Res; 2002; 107():247-58. PubMed ID: 11775453
[TBL] [Abstract][Full Text] [Related]
23. Multiple positive and negative regulators of signaling by the EGF-receptor.
Moghal N; Sternberg PW
Curr Opin Cell Biol; 1999 Apr; 11(2):190-6. PubMed ID: 10209155
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
Peace BE; Hill KJ; Degen SJ; Waltz SE
Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells.
Palmer U; Liu Z; Broomé U; Klominek J
Eur Respir J; 1999 Aug; 14(2):405-11. PubMed ID: 10515421
[TBL] [Abstract][Full Text] [Related]
26. Rational bases for the development of EGFR inhibitors for cancer treatment.
Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
[TBL] [Abstract][Full Text] [Related]
27. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells.
Eguchi S; Iwasaki H; Inagami T; Numaguchi K; Yamakawa T; Motley ED; Owada KM; Marumo F; Hirata Y
Hypertension; 1999 Jan; 33(1 Pt 2):201-6. PubMed ID: 9931105
[TBL] [Abstract][Full Text] [Related]
28. Role of EGF receptor signaling on morphogenesis of eyelid and meibomian glands.
Dong F; Call M; Xia Y; Kao WW
Exp Eye Res; 2017 Oct; 163():58-63. PubMed ID: 28950938
[TBL] [Abstract][Full Text] [Related]
29. Growth factors and their receptors: new targets for prostate cancer therapy.
Barton J; Blackledge G; Wakeling A
Urology; 2001 Aug; 58(2 Suppl 1):114-22. PubMed ID: 11502465
[TBL] [Abstract][Full Text] [Related]
30. Signal transduction: specificity of growth factors explained by parallel distributed processing.
Schamel WW; Dick TP
Med Hypotheses; 1996 Sep; 47(3):249-55. PubMed ID: 8898327
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors.
Defize LH; Boonstra J; Meisenhelder J; Kruijer W; Tertoolen LG; Tilly BC; Hunter T; van Bergen en Henegouwen PM; Moolenaar WH; de Laat SW
J Cell Biol; 1989 Nov; 109(5):2495-507. PubMed ID: 2553748
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma.
Joseph SR; Endo-Munoz L; Gaffney DC; Saunders NA; Simpson F
Curr Probl Dermatol; 2015; 46():20-7. PubMed ID: 25561202
[TBL] [Abstract][Full Text] [Related]
33. Acrolein induces activation of the epidermal growth factor receptor of human keratinocytes for cell death.
Takeuchi K; Kato M; Suzuki H; Akhand AA; Wu J; Hossain K; Miyata T; Matsumoto Y; Nimura Y; Nakashima I
J Cell Biochem; 2001; 81(4):679-88. PubMed ID: 11329622
[TBL] [Abstract][Full Text] [Related]
34. Intracellular signalling cascades activated by the EGF receptor and/or by integrins, with potential relevance for branching morphogenesis of the fetal mouse submandibular gland.
Kashimata MW; Sakagami HW; Gresik EW
Eur J Morphol; 2000 Oct; 38(4):269-75. PubMed ID: 10980679
[TBL] [Abstract][Full Text] [Related]
35. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission.
Gschwind A; Zwick E; Prenzel N; Leserer M; Ullrich A
Oncogene; 2001 Mar; 20(13):1594-600. PubMed ID: 11313906
[TBL] [Abstract][Full Text] [Related]
36. [Epidermal growth factor inhibitors].
Delbaldo C; Faivre S; Raymond E
Rev Med Interne; 2003 Jun; 24(6):372-83. PubMed ID: 12814826
[TBL] [Abstract][Full Text] [Related]
37. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
[TBL] [Abstract][Full Text] [Related]
38. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions.
Alroy I; Yarden Y
FEBS Lett; 1997 Jun; 410(1):83-6. PubMed ID: 9247128
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.
Filardo EJ
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):231-8. PubMed ID: 11897506
[TBL] [Abstract][Full Text] [Related]
40. The epidermal growth factor receptor family: biology driving targeted therapeutics.
Wieduwilt MJ; Moasser MM
Cell Mol Life Sci; 2008 May; 65(10):1566-84. PubMed ID: 18259690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
